Inga Sarrazin

Author Archives

  • CONGEN offers 1.5 millionen SARS-CoV-2 analyzes

    As one of the first manufactures CONGEN designed a molecular test kit for the detection of SARS-CoV-2 . This method enables the qualitative and specific detection of SARS-CoV-2 RNA from human respiratory samples. Until the first development, CONGEN expanded the production capacities, continuously. So far, CONGEN offered more than 1.5 million analyzes for the health […]

  • System Verification with SureCycle®

    To secure precise result laboratories need to control their devices periodically. SureCycle® is a thermosensitive duplex real-time PCR to control the correct temperature during the annealing- and denaturation step. The kit is designed to control compatibility of plastics like tubes, plates and/or foiles and to verify the correct temperature of the real-time cycler. SureCycle® is […]

  • World-Sepsis Day on September 13th

    Every 3.5 seconds 1 human die; 7 to 9 million people each single year caused by sepsis. Sepsis is a life-threatening illness caused by your body’s response to an infection. Everybody can get sepsis caused by infection connected with different types of microorganisms as bacteria, viruses, funghi or parasites. Sepsis can  lead to shock, multiple […]

  • Kary Mullis – the „godfather“ of PCR recently died at the age of 74

    August 2019 – The American biochemist Kary Mullis, born on 28th of December 1944, died on 7th of August 2019. He became famous for his significant contribution to the development of Polymerase Chain Reaction (PCR).  His invention has been awarded with the highly esteemed Nobel Prize in Chemistry which he received together with Michael Smith […]

  • Reforms Regarding Products and Services 2017/2018

    New ServiceLab and Contact Details After 20 years, in November 2017, the CONGEN ServiceLab had moved to new laboratory facilities and is now seperatet from production and research and development. With new equippment and optimized procedures it guaranties a workflow according to current standards and regulations. Please note relevant changes: CONGEN Biotechnologie GmbH ServiceLab Haus […]

  • Topical Issues

    510(k) Premarket Notification Since the beginning of 2017 CONGEN prepares the rebuilding and expansion for planed FDA approval. We proudly announce, starting from now, the first kit for the detection of Norovirus genogroup get the 510(k) Premarket Notification (PMN). The FDA confirms that this device is at least as safe and effective as legally marketed […]

  • Increase of accredited methods

    Our analysis laboratory is accredited by DAkkS in accordance with DIN EN ISO/IEC 17025. This laboratory has exclusively used validated detection methods since 2003. From today following real-time PCR methods are accredited and available: qualitative methods: donkey chicken rabbit horse turkey beef sheep pork water buffalo goat BAR CTP2:CP4 EPSPS CryIAb/IAc NPTII PAT corn canola […]

  • New productline concerning personalized medicine

    Each patient has an individual disposition – physical constitution, age and mental factors. Disease symptomes can vary depending on the dispositon and genetic predisposition. With appropriate diagnostic methods genetic constitution can be determined and effective therapies prescribed. CONGEN develops and optimizes together with experienced partners special diagnostics methods, which are offered as ready-to-use-kits to all […]